Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial
Guardado en:
Autores principales: | Hany M. Dabbous, Manal H. El‑Sayed, Gihan El Assal, Hesham Elghazaly, Fatma F. S. Ebeid, Ahmed F. Sherief, Maha Elgaafary, Ehab Fawzy, Sahar M. Hassany, Ahmed R. Riad, Mohamed A. TagelDin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4b565f65ac4a46f0bd15948e52f78885 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial
por: Hany M. Dabbous, et al.
Publicado: (2021) -
Favipiravir Inhibits Mayaro Virus Infection in Mice
por: Michèle Bengue, et al.
Publicado: (2021) -
Synthesis of β-Enaminonitrile-Linked 8-Methoxy-1H-Benzo[f]Chromene Moieties and Analysis of Their Antitumor Mechanisms
por: Menna Elgaafary, et al.
Publicado: (2021) -
Evaluation of favipiravir treatment before intensive care in COVID-19 patients
por: Osman Ozudogru, et al.
Publicado: (2021) -
Prevalence of Headache in Children with Epilepsy
por: Sherief M. Al shazly, et al.
Publicado: (2021)